DK0683669T3 - Fremgangsmåder og præparater af en polymer (poloxamer) til cellereparation - Google Patents

Fremgangsmåder og præparater af en polymer (poloxamer) til cellereparation

Info

Publication number
DK0683669T3
DK0683669T3 DK93905944T DK93905944T DK0683669T3 DK 0683669 T3 DK0683669 T3 DK 0683669T3 DK 93905944 T DK93905944 T DK 93905944T DK 93905944 T DK93905944 T DK 93905944T DK 0683669 T3 DK0683669 T3 DK 0683669T3
Authority
DK
Denmark
Prior art keywords
surface active
methods
disclosed
active copolymer
compositions
Prior art date
Application number
DK93905944T
Other languages
Danish (da)
English (en)
Inventor
Raphael C Lee
Original Assignee
Arch Dev Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arch Dev Corp filed Critical Arch Dev Corp
Application granted granted Critical
Publication of DK0683669T3 publication Critical patent/DK0683669T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Polyethers (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
DK93905944T 1992-02-13 1993-02-12 Fremgangsmåder og præparater af en polymer (poloxamer) til cellereparation DK0683669T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/835,271 US5470568A (en) 1992-02-13 1992-02-13 Methods and compositions of a polymer (poloxamer) for cell repair
PCT/US1993/001327 WO1993015745A1 (en) 1992-02-13 1993-02-12 Methods and compositions of a polymer (poloxamer) for cell repair

Publications (1)

Publication Number Publication Date
DK0683669T3 true DK0683669T3 (da) 2003-01-06

Family

ID=25269083

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93905944T DK0683669T3 (da) 1992-02-13 1993-02-12 Fremgangsmåder og præparater af en polymer (poloxamer) til cellereparation

Country Status (7)

Country Link
US (1) US5470568A (de)
EP (1) EP0683669B1 (de)
AT (1) ATE223222T1 (de)
AU (1) AU3667293A (de)
DE (1) DE69332275T2 (de)
DK (1) DK0683669T3 (de)
WO (1) WO1993015745A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202225B1 (en) * 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
US20020123476A1 (en) * 1991-03-19 2002-09-05 Emanuele R. Martin Therapeutic delivery compositions and methods of use thereof
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6277410B1 (en) 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US5608520A (en) * 1994-07-11 1997-03-04 The United States Of America As Represented By He Department Of Energy Plasma emission spectroscopy method of tumor therapy
GB9417742D0 (en) * 1994-09-03 1994-10-19 Univ Nottingham Macrophage stimulating composition
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
US6040295A (en) 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
DE19537494C2 (de) * 1995-09-25 1997-10-02 Desitin Arzneimittel Gmbh Kreatin zum Schutz von neuralem Gewebe
US6323549B1 (en) * 1996-08-29 2001-11-27 L. Pierre deRochemont Ceramic composite wiring structures for semiconductor devices and method of manufacture
AU6358898A (en) 1996-09-09 1998-04-17 Alexander V Kabanov Fluorinated copolymeric pharmaceutical adjuncts
WO2000009732A1 (en) * 1998-08-13 2000-02-24 Warner-Lambert Company Electroporation buffer with cryprotective capabilities
US7582680B1 (en) 1998-11-12 2009-09-01 Purdue Research Foundation Methods and compositions for treating mammalian spinal cord injuries
WO2001065911A2 (en) * 2000-03-03 2001-09-13 Valentis, Inc. Improved poloxamer and poloxamine compositions for nucleic acid delivery
US6875748B2 (en) * 2000-04-21 2005-04-05 Vical Incorporated Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
EP1283727A4 (de) * 2000-04-28 2007-10-10 Supratek Pharma Inc Zusammensetzungen und verfahren zum induzieren von aktivierung dentritischer zellen
MY128134A (en) * 2000-09-28 2007-01-31 Novartis Ag Compositions and methods for cleaning contact lenses
US20040009940A1 (en) * 2000-10-20 2004-01-15 Coleman Michael E. Gene delivery formulations and methods for treatment of ischemic conditions
WO2002092107A1 (en) * 2001-04-24 2002-11-21 Purdue Research Foundation Method and compositions for treating mammalian nerve tissue injuries
US20030191081A1 (en) * 2001-12-28 2003-10-09 Pierre Lemieux Pharmaceutical compositions and methods of use thereof comprising polyanionic polymers and amphiphilic block copolymers to improve gene expression
FR2835749B1 (fr) 2002-02-08 2006-04-14 Inst Nat Sante Rech Med Composition pharmaceutique ameliorant le transfert de gene in vivo
US20050008610A1 (en) 2003-03-24 2005-01-13 Alexander Schwarz Temporary embolization using inverse thermosensitive polymers
WO2005046438A2 (en) * 2003-11-06 2005-05-26 Pluromed, Inc. Internal clamp for surgical procedures
WO2005102363A2 (en) * 2004-04-20 2005-11-03 Mucosal Therapeutics Llc Methods of promoting cartilage healing or cartilage integration
EP1809272A4 (de) * 2004-10-18 2008-01-02 Maroon Biotech Corp Verfahren und zusammensetzungen zur behandlung von schäden durch freie radikale
US20100047413A1 (en) * 2006-09-15 2010-02-25 Cabalka Tourtellotte Leanne M Method of using amphiphilic multiblock copolymers in food
AU2008218746B2 (en) 2007-02-19 2014-03-13 Plurogen Therapeutics, Inc. Compositions for treating biofilms and methods for using same
US8512695B2 (en) * 2008-10-21 2013-08-20 The General Hospital Corporation Method of preventing fat graft resorption by administering fat-derived cells and poloxamer P 188
CN103153376B (zh) 2010-08-06 2018-04-20 通用医院公司以麻省总医院名义经营 用于细胞处理相关应用的系统和设备
EP3003325A4 (de) * 2013-05-29 2017-01-11 Biogen MA Inc. Verfahren zur bewertung von zellkultur-zusatzstoffen
EP3247364A4 (de) 2015-01-20 2018-10-24 Plurogen Therapeutics, LLC Zusammensetzungen und verfahren zur behandlung von mikroben
WO2022011311A1 (en) * 2020-07-09 2022-01-13 Musc Foundation For Research Development Methods of protecting cells from insults
WO2022051713A1 (en) * 2020-09-04 2022-03-10 The University Of Chicago Materials and methods of treating viral infection with amphiphilic block copolymers

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29909A (en) * 1860-09-04 Ebenezer G Pomeroy Improved method of converting iron into steel
US2674619A (en) * 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US2854378A (en) * 1955-12-08 1958-09-30 Bristol Lab Inc Tetracycline suppository
GB840155A (en) * 1958-01-30 1960-07-06 Louis Lafon Improvements in or relating to pharmaceutical compositions
US3089818A (en) * 1960-06-02 1963-05-14 Baxter Laboratories Inc Water dispersible antibiotics
GB983130A (en) * 1962-08-06 1965-02-10 Mundipharma Ag Improvements in preparations for the removal of wax from the ear
US3140232A (en) * 1962-12-19 1964-07-07 Pfizer & Co C Color stabilization of tetracycline compositions with polypropylene glycols
US3740421A (en) * 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
US3639575A (en) * 1968-06-19 1972-02-01 Basf Wyandotte Corp Silver ion gel compositions and method of using the same
AU418761B2 (en) * 1968-09-19 1971-11-06 Phosiological salt solutions of ethylene oxide-polypropylene glycol condensation products
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
US3590125A (en) * 1969-10-10 1971-06-29 Wyandotte Chemicals Corp Physiological salt solutions of ethylene oxide-polypropylene glycol condensation products as blood plasma substitutes
US3577522A (en) * 1969-10-10 1971-05-04 Wyandotte Chemicals Corp Methods for the treatment of shock with ethylene oxide-polypropylene glycol condensates as blood plasma substitutes
US3980772A (en) * 1969-12-02 1976-09-14 Baxter Laboratories, Inc. Methods of dissolving blood clots and the like with streptokinase chemically bonded to a carbohydrate matrix
US3867521A (en) * 1970-08-26 1975-02-18 Scherer Corp R P Method for absorption of drugs
US4073886A (en) * 1973-01-30 1978-02-14 Baxter Travenol Laboratories, Inc. Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US3956259A (en) * 1973-01-30 1976-05-11 Baxter Laboratories, Inc. Fractionation of blood using block copolymer of ethylene oxide and polyoxypropylene polymer to recover fraction suitable for organ perfusate
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US3997458A (en) * 1974-04-12 1976-12-14 Deknatel, Incorporated Method of cleansing contaminated wounds and surgical scrub solutions for same
US4105650A (en) * 1975-04-11 1978-08-08 Edward Shanbrom, Inc. Method of preserving blood plasma i
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4305922A (en) * 1978-10-04 1981-12-15 University Patents, Inc. Labeling proteins with 99m-Tc by ligand exchange
US4186253A (en) * 1978-10-10 1980-01-29 The Green Cross Corporation Perfusate for preserving organ to be transplanted and preserving method
US4395393A (en) * 1981-08-10 1983-07-26 Basf Wyandotte Corporation Artificial blood emulsifiers
US4407790A (en) * 1981-09-25 1983-10-04 Economics Laboratory, Inc. Method of controlling bloat using nonionic surfactants
CA1244774A (en) * 1983-11-09 1988-11-15 Thomas Jefferson University Medium for storing blood platelets
US4600652A (en) * 1985-04-01 1986-07-15 Warner-Lambert Company Permanently bonded antithrombogenic polyurethane surface
JPH084504B2 (ja) * 1985-04-26 1996-01-24 味の素株式会社 安定化ス−パ−オキサイドジスムタ−ゼ
US5039520A (en) * 1986-05-15 1991-08-13 Emory University Plasma extender
US4897263A (en) * 1986-05-15 1990-01-30 Emory University Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids
US5064643A (en) * 1986-05-15 1991-11-12 Emory University Method for treating sickle cell disease
US5078995A (en) * 1986-05-15 1992-01-07 Emory University Fibrionolytic composition
US5028599A (en) * 1986-05-15 1991-07-02 Emory University Method of treating mycardial damage
US5089260A (en) * 1986-05-15 1992-02-18 Emory University Method of treating ischemic tissue
US5041288A (en) * 1986-05-15 1991-08-20 Emory University Method of treating tissue damaged by reperfusion injury
US4937070A (en) * 1986-05-15 1990-06-26 Emory University Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids
US4873083A (en) * 1986-05-15 1989-10-10 Emory University Fibrinolytic composition
US5030448A (en) * 1986-05-15 1991-07-09 Emory University Method of delivering drugs to damaged or diseased tissue
US5017370A (en) * 1986-05-15 1991-05-21 Emory University Improved method of performing angioplasty procedures
US5032394A (en) * 1986-05-15 1991-07-16 Emory University Method of treating burns
DE3751907T2 (de) * 1986-05-15 1997-04-03 Univ Emory Injizierbares Arzneimittel zum Schutz vor Gewebebeschädigung durch Ischemie
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4801452A (en) * 1986-05-15 1989-01-31 Hunter Robert L Fibrinolytic composition
US5080894A (en) * 1986-05-15 1992-01-14 Emory University Method and composition for reducing tissue damage
WO1987006831A1 (en) * 1986-05-15 1987-11-19 Emory University Composition and method for treating a thrombus and embolus
US5071649A (en) * 1986-05-15 1991-12-10 Emory University Method of preventing blockage in catheters
US4837014A (en) * 1986-05-15 1989-06-06 Emory University An improved method of treating sickle cell anemia
US5152979A (en) * 1986-05-15 1992-10-06 Emory University Method for treating vascular obstructions caused by abnormal cells
US5047236A (en) * 1986-05-15 1991-09-10 Emory University Method of treating stroke
US5045468A (en) * 1986-12-12 1991-09-03 Cell Enterprises, Inc. Protein-free culture medium which promotes hybridoma growth
US5075333A (en) * 1987-08-19 1991-12-24 Hoffmann-La Roche Inc. Tetrahydronaphthalene and indane compounds useful for reversing the photo-damage in sun-exposed skin
US5002965A (en) * 1989-05-09 1991-03-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Use of ginkgolides to prevent reperfusion injury in organ transplantation
US4997664A (en) * 1989-09-05 1991-03-05 Bryan Foods, Inc. Method for packaging food products

Also Published As

Publication number Publication date
DE69332275D1 (de) 2002-10-10
AU3667293A (en) 1993-09-03
EP0683669A4 (de) 1995-08-11
WO1993015745A1 (en) 1993-08-19
US5470568A (en) 1995-11-28
DE69332275T2 (de) 2003-04-17
ATE223222T1 (de) 2002-09-15
EP0683669A1 (de) 1995-11-29
EP0683669B1 (de) 2002-09-04

Similar Documents

Publication Publication Date Title
DK0683669T3 (da) Fremgangsmåder og præparater af en polymer (poloxamer) til cellereparation
NO960743L (no) Cellulære preparater, deres fremstilling og terapeutiske anvendelse
NO953093D0 (no) Forbindelser med både sterk kalsiumantagonist- og antioksidantvirkning, samt anvendelse derav som cellebeskyttende midler
MX9306029A (es) Composiciones protectoras y regenerativas de tejidos.
EA200500149A1 (ru) Тканевые протективные цитокины для защиты, восстановления и стимуляции реактивных клеток, тканей и органов
WO1995017899A3 (en) Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
DK0726768T3 (da) Anvendelse af nitrogenoxidfrigørende forbindelser til fremstillingen af et medikament til beskyttelse i iskæmisk reperfusio
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
IL85746A0 (en) Preparation of t cells and t cell membrane for use in autoimmune diseases
BR9910251A (pt) Estimulação hematopoiética
MX9603074A (es) Vitamina e y derivados que previenen el daño en celulas rojas esterilizadas mediante ftalocianinas y luz.
DK0933995T3 (da) Fremgangsmåde til behandling af endotelskader
CA2130360A1 (en) Sulfonic Acid Derivatives in the Treatment of Viral Diseases
WO2003024406A3 (en) Nestin-expressing hair follicle stem cells
DK0611572T3 (da) Fremgangsmåde til fremstilling af et frysetørret cetrorelix præparat
AU2883192A (en) Combined cellular and immunosuppressive therapies
AR022583A1 (es) Secuencias antitumorales anti-sentido dirigidas contra los componentes r1 y r2 de la reductasa de los ribonucleotidos
EA200501828A1 (ru) Тканепротекторные цитокины с увеличенным терапевтическим окном для защиты, восстановления и стимулирования реагирующих клеток, тканей и органов
AR017368A1 (es) Un procedimiento para la insercion de adn foraneo en una celula hospedante, un vector recombinante utilizado en dicho procedimiento y el uso del mismo
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
ATE264674T1 (de) Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
TR199902786T2 (xx) Ba����kl�k sistemi faaliyetinin d�zene sokulmas� ve iltihaplanman�n durdurulmas� i�in lipofilik peptidlerin h�cre yap�s�n�n d�zene konulmas�.
PL326629A1 (en) Application of flupyrtin in prophylaxy and therapy of deseases associated with damaged hematopoietic cellular system
ATE391508T1 (de) Zusammensetzungen mit amphotericin b enthaltend weniger als 4 verunreinigungen
DK0793503T3 (da) Anvendelse af hepatocyt-vækstfaktor til inducering af profilerering og differentiering af hemotopoietiske celler